Candel Therapeutics Inc. (CADL)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 18
+0.7
+7.384%
$
541.87M Market Cap
- P/E Ratio
- Div Yield
2.38M Volume
-0.91 Eps
$ 9.48
Previous Close 
Want to track CADL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Candel Therapeutics Inc. (CADL) Statistics
Valuation metrics
Market Cap 541.87M
Enterprise value 365.85M
Trailing P/E (ttm) -10.35
Forward P/E -
PEG ratio 0.21
Price/Sales (ttm) -
Price/Book (mrq) 4.6
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.46M
Average volume (90 days) 2.2M
Price summary
52-Week low 4.35
52-Week high 11.36
Beta -
50-Day moving average 9.41
200-Day moving average 6.35
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.27%
Return on equity -0.6%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.12
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 28.05%
Book value per share (mrq) 2.21
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
